News

The small molecule CFTR modulators market targets cystic fibrosis treatment, driven by innovative therapies, rising prevalence ...
Most children with CF treated at a San Francisco CF clinic did not receive CF liver disease screening in accordance with current guidelines.
Without Medicaid, the level of care that Walter and other children like him require on an ongoing basis would be inaccessible to families. Yet that is what members of Congress are currently ...
VRTX secures EU approval for Alyftrek, a next-in-class triple combination regimen for treating people with CF aged six years ...
Panelists discuss how emerging, better-tolerated oral therapies for idiopathic pulmonary fibrosis (IPF) and progressive ...
With its blockbuster Trikafta set to lose patent protection within the decade, Vertex is strengthening its cystic fibrosis ...
Vertex Pharmaceuticals today announced that the European Commission has granted approval for Alyftrek ...
Vertex Pharmaceuticals (VRTX) on Tuesday announced that the European Commission has granted approval for Alyftrek for the ...
Vertex Pharmaceuticals said on Tuesday its next-generation cystic fibrosis treatment has won European Union approval for a ...
Ben is running 12 marathons in 12 months to raise awareness for cystic fibrosis, a condition he's battled since childhood.
Microbiome-directed therapy for cystic fibrosis exacerbations currently fails to improve lung function and may increase ...
At 7 years old, Morgan Barrett was diagnosed with cystic fibrosis. Prior to her diagnosis, she struggled to gain weight ...